logo

For the Inventor, By the Inventor

New York, NY, United States of America

Sloan-kettering Institute for Cancer Research


USPTO Granted Patents = 512



Forward Citations = 6,218

Loading Chart...
Loading Chart...

789 inventors (with patents filed for the assignee):

goldMedal Samuel J Danishefsky (76 out of 94 patents)

silverMedal Lloyd J Old (32 out of 122 patents)

bronzeMedal Ting-Chao Chou (28 out of 37 patents)

4.  Philip O Livingston (28 out of 33 patents)

5.  Alan N Houghton (26 out of 28 patents)

6.  Nai-Kong V Cheung (21 out of 49 patents)

7.  David A Scheinberg (21 out of 49 patents)

8.  Paul A Marks (21 out of 27 patents)

9.  Kyoichi A Watanabe (21 out of 24 patents)

10.  Richard A Rifkind (19 out of 22 patents)

11.  Kenneth O Lloyd (19 out of 28 patents)

12.  Herbert F Oettgen (19 out of 20 patents)

13.  Kenneth Allen Savin (17 out of 22 patents)

14.  Gabriela Chiosis (16 out of 34 patents)

15.  Ouathek Ouerfelli (16 out of 25 patents)


Core Competencies:
PI3K Inhibitors
Neurodegenerative Diseases
Ocular Prosthesis
Chimeric Receptors
Silica-Based Nanoparticles
CDC7 Kinase Inhibitors
HSP90 Inhibitors
Endothelial Cell Proliferation
Mitragynine Analogs
Glucocorticoid Inhibitors
Exosomal DNA Biomarkers
Monoclonal Antibodies

512 patents:

1. 12478616 - PI3K inhibitors and uses thereof (2025-11-25),
2. 12473288 - Treatment of neurodegenerative diseases through inhibiton of Hsp90 (2025-11-18),
3. 12336902 - Ocular prosthesis with display device (2025-06-24),
4. 12331129 - Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof (2025-06-17),
5. 12227535 - Triterpene saponins, methods of synthesis and uses thereof (2025-02-18),
6. 12221489 - Antibodies to human B7x for treatment of metastatic cancer (2025-02-11),
7. 12161734 - Multimodal silica-based nanoparticles (2024-12-10),
8. 12121525 - Methods for treating GI syndrome and graft versus host disease (2024-10-22),
9. 12109189 - CDC7 kinase inhibitors and uses thereof (2024-10-08),
10. 11913021 - Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis (2024-02-27),
11. 11760758 - Mitragynine analogs for the treatment of pain, mood disorders and substance use disorders (2023-09-19),
12. 11666550 - CDC7 kinase inhibitors and uses thereof (2023-06-06),
13. 11607465 - Uses of labeled HSP90 inhibitors (2023-03-21),
14. 11564988 - Single wall nanotube constructs and uses thereof (2023-01-31),
15. 11447515 - Triterpene saponins, methods of synthesis and uses thereof (2022-09-20),
Sloan-Kettering Institute for Cancer Research is a world-renowned cancer research institute dedicated to advancing the understanding and treatment of cancer. With a focus on innovative research, exceptional patient care, and education, the institute has made significant contributions to the field of oncology. Their website provides valuable information about the institute's research programs, clinical trials, patient care services, and educational resources.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
512 Patents

#32 in New York, NY

#58 in New York

#920 in US

#1,839 in the World

...
New York, NY, United States of America

Sloan-kettering Institute for Cancer Research

Forward Citations = 6,218

789 inventors:

goldMedal Samuel J Danishefsky (76 out of 94 patents)

silverMedal Lloyd J Old (32 out of 122 patents)

bronzeMedal Ting-Chao Chou (28 out of 37 patents)

4.  Philip O Livingston (28 out of 33 patents)

5.  Alan N Houghton (26 out of 28 patents)

Please report any incorrect information to support@idiyas.com
Loading…